Alaunos Therapeutics TCRT
NASDAQ TCRT
$0.88 -0.03 (-3.69%)
As of: Oct 2, 2026 · 1:06 PM EDT

Alaunos Therapeutics (TCRT) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Alaunos Therapeutics (TCRT) reported Liabilities and Shareholders Equity of $1.52 million for Q2 2026, down 68.0% from $4.74 million a year earlier and down 19.5% from the prior quarter.

Analysis

Alaunos Therapeutics (TCRT) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

At the end of FY2025, Alaunos Therapeutics posted Liabilities and Shareholders Equity of $2.97 million, up 7.7% from FY2024.

  • Liabilities and Shareholders Equity has a five-year compound annual growth rate of -54.1% (FY2020 to FY2025).
  • By year, Liabilities and Shareholders Equity came in at $2.76 million in FY2024 (-66.7%), $8.26 million in FY2023 (-87.3%), $64.94 million in FY2022 (-31.5%) and $94.87 million in FY2021 (-35.2%).
  • The Q2 2026 figure ranks as the lowest quarterly Liabilities and Shareholders Equity in data going back to Q4 2009.
  • Year over year, Liabilities and Shareholders Equity gained in three of the last eight quarters, with an average decline of 34.8%.
  • The high point for year-over-year Liabilities and Shareholders Equity in five years was Q4 2025 (growth of 7.7%); the low point was Q1 2024 (a decline of 87.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $1.88 million (Q1 2026), $2.97 million (Q4 2025) and $3.72 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Alaunos Therapeutics 2.19 Mn -1.61 Mn - 1.52 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.52 Mn
Mar 31, 2026 1.88 Mn
Dec 31, 2025 2.97 Mn
Sep 30, 2025 3.72 Mn
Jun 30, 2025 4.74 Mn
Mar 31, 2025 2.12 Mn
Dec 31, 2024 2.76 Mn
Sep 30, 2024 3.55 Mn
Jun 30, 2024 4.68 Mn
Mar 31, 2024 6.04 Mn
Dec 31, 2023 8.26 Mn
Sep 30, 2023 19.44 Mn
Jun 30, 2023 27.93 Mn
Mar 31, 2023 48.64 Mn
Dec 31, 2022 64.94 Mn
Sep 30, 2022 67.34 Mn
Jun 30, 2022 73.93 Mn
Mar 31, 2022 84.99 Mn
Dec 31, 2021 94.87 Mn
Sep 30, 2021 113.76 Mn
API Access

Alaunos Therapeutics Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TCRT&period=max&api_key=YOUR_API_KEY